Literature DB >> 18268186

Protein misfolding and neurodegeneration.

Claudio Soto1, Lisbell D Estrada.   

Abstract

A key molecular pathway implicated in diverse neurodegenerative diseases is the misfolding, aggregation, and accumulation of proteins in the brain. Compelling evidence strongly supports the hypothesis that accumulation of misfolded proteins leads to synaptic dysfunction, neuronal apoptosis, brain damage, and disease. However, the mechanism by which protein misfolding and aggregation trigger neurodegeneration and the identity of the neurotoxic structure is still unclear. The aim of this article is to review the literature around the molecular mechanism and role of misfolded protein aggregates in neurodegeneration and the potential for the misfolding process to lead to a transmissible form of disease by a prion-based model of propagation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268186     DOI: 10.1001/archneurol.2007.56

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  108 in total

1.  Dynamic imaging by fluorescence correlation spectroscopy identifies diverse populations of polyglutamine oligomers formed in vivo.

Authors:  Monica Beam; M Catarina Silva; Richard I Morimoto
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Polyglutamine misfolding in yeast: toxic and protective aggregation.

Authors:  Martin L Duennwald
Journal:  Prion       Date:  2011-10-01       Impact factor: 3.931

Review 3.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

4.  Effects of Congo red on aβ(1-40) fibril formation process and morphology.

Authors:  Partha Pratim Bose; Urmimala Chatterjee; Ling Xie; Jan Johansson; Emmanuelle Göthelid; Per I Arvidsson
Journal:  ACS Chem Neurosci       Date:  2010-02-03       Impact factor: 4.418

5.  Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization.

Authors:  Hyung Jin Ahn; Daria Zamolodchikov; Marta Cortes-Canteli; Erin H Norris; J Fraser Glickman; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

6.  Reversibility of prion-induced neurodegeneration.

Authors:  Claudio Soto
Journal:  Lancet Neurol       Date:  2007-04       Impact factor: 44.182

7.  Conformational isomers of denatured and unfolded proteins: methods of production and applications.

Authors:  Jui-Yoa Chang
Journal:  Protein J       Date:  2009-01       Impact factor: 2.371

Review 8.  Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door?

Authors:  Subhankar Paul; Sailendra Mahanta
Journal:  Mol Cell Biochem       Date:  2013-10-05       Impact factor: 3.396

Review 9.  Sorting out the trash: the spatial nature of eukaryotic protein quality control.

Authors:  Emily Mitchell Sontag; Willianne I M Vonk; Judith Frydman
Journal:  Curr Opin Cell Biol       Date:  2014-01-23       Impact factor: 8.382

Review 10.  A cellular perspective on conformational disease: the role of genetic background and proteostasis networks.

Authors:  Tali Gidalevitz; Elise A Kikis; Richard I Morimoto
Journal:  Curr Opin Struct Biol       Date:  2010-01-05       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.